Galecto

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galecto and other ETFs, options, and stocks.

About GLTO

Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211. 

CEO
Hans Thalsgård Schambye
CEOHans Thalsgård Schambye
Employees
40
Employees40
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2011
Founded2011
Employees
40
Employees40

GLTO Key Statistics

Market cap
50.28M
Market cap50.28M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
63.17K
Average volume63.17K
High today
$2.03
High today$2.03
Low today
$1.91
Low today$1.91
Open price
$2.01
Open price$2.01
Volume
22.42K
Volume22.42K
52 Week high
$3.87
52 Week high$3.87
52 Week low
$1.17
52 Week low$1.17

GLTO Earnings

-$0.86
-$0.57
-$0.29
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.